Allergan Sues Apotex Over Latisse ANDA
Allergan Inc. has sued Apotex Inc. in an effort to prevent the Toronto-based drugmaker from introducing a generic version of Latisse, a treatment used to stimulate eyelash growth....To view the full article, register now.
Already a subscriber? Click here to view full article